Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
2.
J Dairy Sci ; 98(12): 8359-67, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26409965

ABSTRACT

In the present study, the effect of feed Se supplementation on the Se content of raw milk and mozzarella cheese as well as the effect on cheese quality and functionality were determined. The Se milk was produced by supplying dairy cow feed with Se yeast (0.3mg of Se/kg of dry matter), resulting in a Se concentration in milk of 35.81µg/L. The fat, casein, and whey protein of Se milk were separated by ultracentrifugation, and the Se content was determined by atomic absorption spectroscopy. The Se distribution in different milk fractions of fat, casein, and whey protein were 9.82, 45.56, and 44.62%, respectively. The Se mozzarella cheese was made by Se milk, and the composition and texture of Se cheese did not significantly differ from that of the control. However, the functional properties (meltability, flowability, and stretchability) of the Se cheese were better after 8 wk of storage. Moreover, the pH and water activity were lower in Se cheese, which decreased the total plate count. The Se content in mozzarella cheese was 4 fold higher than that in milk, and Se was found in the whey, hot water, and brine collected during cheesemaking. Organic and inorganic Se was found in the Se cheese after 8 wk of storage, and most Se peptides detected after storage were Se-Met and Se-Cys. The results of this study show that feed Se supplementation can improve the Se content of milk and cheese without affecting mozzarella cheese quality.


Subject(s)
Animal Feed/analysis , Cheese/analysis , Food Quality , Selenium/administration & dosage , Animals , Caseins/analysis , Cattle , Colony Count, Microbial , Diet/veterinary , Dietary Supplements , Fatty Acids/analysis , Female , Hydrogen-Ion Concentration , Milk/chemistry , Selenium/analysis , Whey Proteins
3.
Int J Tuberc Lung Dis ; 16(5): 633-8, 2012 May.
Article in English | MEDLINE | ID: mdl-22410137

ABSTRACT

SETTING: A prison in northern Taiwan. OBJECTIVE: To compare safety and the completion rate of the 4-month daily rifampicin regimen (4R) vs. the standard 6-month daily isoniazid regimen (6H) for latent tuberculosis infection (LTBI) in prison inmates. DESIGN: This was an open-label randomised trial among human immunodeficiency virus negative male inmates. Inmates without active tuberculosis (TB) who tested positive for both the tuberculin skin test and QuantiFERON®-TB Gold In-Tube were eligible, but those with baseline glutamic pyruvic transaminase (GPT) levels ≥ 120 U/l, bilirubin levels ≥ 2.4 U/l or a platelet count < 150 k/mm(3) were excluded. The primary endpoint was any adverse event that resulted in discontinuation of LTBI treatment. RESULTS: Participants (n = 373; 14% hepatitis B surface antigen positive, 21% anti-hepatitis C virus [HCV] positive) were randomised (stratified by hepatitis B virus, HCV status and 2-year prison term) to receive either 4R or 6H under directly observed treatment. The 4R group (n = 190) was less likely to experience an adverse event leading to discontinuation of treatment (2% vs. 12%, P < 0.001 for all adverse events; 0% vs. 8%, P < 0.001 for hepatotoxicity), and more likely to complete LTBI treatment (86% vs. 78%, P = 0.041), compared with the 6H group (n = 183). CONCLUSIONS: 4R is safer and has a higher completion rate than 6H as treatment for LTBI among male prison inmates.


Subject(s)
Antitubercular Agents/therapeutic use , Isoniazid/therapeutic use , Latent Tuberculosis/drug therapy , Rifampin/therapeutic use , Adolescent , Adult , Aged , Antitubercular Agents/administration & dosage , Antitubercular Agents/adverse effects , Follow-Up Studies , Humans , Interferon-gamma Release Tests , Male , Medication Adherence , Middle Aged , Prisoners , Rifampin/administration & dosage , Rifampin/adverse effects , Taiwan , Treatment Outcome , Tuberculin Test , Young Adult
4.
Parasitol Res ; 88(13 Suppl 1): S22-4, 2002 May.
Article in English | MEDLINE | ID: mdl-12051601

ABSTRACT

Haemaphysalis qinghaiensis ticks collected in the Gannan Tibet Autonomous Region were infested onto a sheep from a Babesia-free area. A strain of small Babesia (1.8-2.1 microm in length) was isolated from the sheep. Most of the Babesia in erythrocytes were round, oval, single pyriform, double pyriform, budding or elongated in form. Measurements were made of 100 single sides of the double-pyriform Babesia and compared with those for B. motasi and B. ovis from Holland, using Student's t-test. The Gannan small Babesia was similar to the B. ovis from Holland, but differed significantly from the Dutch B. motasi.


Subject(s)
Arachnid Vectors/parasitology , Babesia/pathogenicity , Babesiosis/veterinary , Ixodidae/parasitology , Sheep Diseases/parasitology , Tick Infestations/parasitology , Animals , Babesia/physiology , Babesiosis/parasitology , Parasitemia/parasitology , Parasitemia/veterinary , Sheep/parasitology , Sheep Diseases/physiopathology , Virulence
5.
Biochemistry ; 40(44): 13390-6, 2001 Nov 06.
Article in English | MEDLINE | ID: mdl-11683649

ABSTRACT

Three novel conformational isomers of mouse prion protein mPrP(23-231) were prepared by incubating the reduced mPrP(23-231) in the presence of urea at mild acidic conditions. They are stable isomers that can be separated and isolated by reversed phase HPLC. These isomers, designated mPrP-a, mPrP-b, and mPrP-c, all exist in reduced state and monomeric form. They all exhibit a high content of beta-sheet structure upon oligomerization at near-neutral pH. They are also partially resistant to proteolysis by proteinase K and chymotrypsin. These structural properties are hallmarks of pathogenic prion protein (PrP(SC)).


Subject(s)
PrPSc Proteins/chemistry , PrPSc Proteins/isolation & purification , Animals , Chromatography, High Pressure Liquid , Chymotrypsin/pharmacology , Circular Dichroism , Endopeptidase K/pharmacology , Kinetics , Light , Mass Spectrometry , Mice , Molecular Weight , Oxidation-Reduction , Peptide Fragments/chemistry , Peptide Fragments/genetics , Peptide Fragments/ultrastructure , Plasmids , Protein Conformation , Protein Denaturation , Protein Folding , Protein Isoforms/chemistry , Protein Isoforms/isolation & purification , Protein Structure, Secondary , Spectrophotometry , Urea/chemistry
6.
Eur J Biochem ; 268(13): 3767-73, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11432744

ABSTRACT

A systematic study of the oxidative folding of murine prion protein mPrP(23-231) is reported here. Folding of mPrP(23-231) involves formation of a single disulfide bond, Cys179-Cys214. Despite this simplicity, reduced mPrP(23-231) exhibits numerous unusual folding properties. In the absence of denaturant, folding of mPrP(23-231) is extremely sluggish, regardless of pH. The optimal pH for mPrP(23-231) folding was found to be 4-5. At pH 8.0, a condition that typically favors disulfide formation, folding of mPrP(23-231) hardly occurs, and it not facilitated by inclusion of redox agent. In the presence of denaturant (4 M urea or 2 M guanidine hydrochloride) and basic pH (8.0), reduced mPrP(23-231) refolds to the native structure quantitatively. The efficiency of folding can be further promoted by the presence of oxidized glutathione. At pH 4.0 and in the presence of 4 M urea, reduced mPrP(23-231) converts to three distinctive conformational isomers, unable to form the native structure. These unusual properties lead us to the following conclusions. The reduced mPrP(23-231) adopts a highly rigid structure with the two cysteines buried or situated apart. The presence of denaturant or low pH disrupts this rigid structure and lowers the energy barrier, which permits oxidation and refolding of the reduced mPrP(23-231). Under selected conditions, reduced mPrP(23-231) is capable of taking on multiple forms of stable conformational isomer that are segregated by energy barriers.


Subject(s)
Peptide Fragments/chemistry , Prions/chemistry , Protein Folding , Animals , Circular Dichroism , Disulfides , Guanidine , Light , Mice , Oxidation-Reduction , Peptide Fragments/metabolism , Prions/metabolism , Protein Conformation , Protein Denaturation , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Scattering, Radiation , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Urea
7.
Med Eng Phys ; 22(4): 253-63, 2000 May.
Article in English | MEDLINE | ID: mdl-11018457

ABSTRACT

This study investigates the optimal external parameters for using an ultrasound applicator for treating bone tumors. This system utilized spherically arranged applicators such as scanned focused ultrasound, and spherically focused multielement applicators. The power deposition pattern is modeled as geometric gain with exponential attenuation. The specific absorption rate ratio (SARR) criteria have been used to determine the proper heating domain of ultrasound driving frequency and therapeutic tumor diameter. The results demonstrate that the optimal driving frequency depends on tumor depth, ultrasound absorption of bone marrow, and diameter of bone, but it is independent of the acoustic window area and SARR. The treatable diameter of bone tumor increased when the absorption ratio of bone marrow to tumor, acoustic window of surface skin, and diameter of bone were elevated. However, the treatable diameter of bone tumor decreased when muscle thickness, SARR of bone tumor site to the surface skin, bone marrow, and bone declined. To deliver the ultrasound energy into the tumor site and to avoid the potential damage to the normal tissue as much as possible, the specific absorption rate (SAR) in the bone tumor site has to be three times higher than that in the surface skin, tumor/marrow, and marrow/bone interfaces. The temperature distributions can verify the SARR criteria in this model. This study provides the information for choosing the optimal operating frequency of the ultrasound transducer and the acoustic window on the skin surface, and for designing the ultrasound applicator for clinical implementation.


Subject(s)
Bone Neoplasms/therapy , Ultrasonic Therapy , Biomedical Engineering , Bone Marrow/pathology , Bone Neoplasms/blood supply , Bone Neoplasms/pathology , Humans , Models, Theoretical , Temperature , Ultrasonic Therapy/instrumentation , Ultrasonic Therapy/methods
8.
Genetics ; 155(2): 699-708, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10835392

ABSTRACT

The Su(var)2-5 locus, an essential gene in Drosophila, encodes the heterochromatin-associated protein HP1. Here, we show that the Su(var)2-5 lethal period is late third instar. Maternal HP1 is still detectable in first instar larvae, but disappears by third instar, suggesting that developmentally late lethality is probably the result of depletion of maternal protein. We demonstrate that heterochromatic silencing of a normally euchromatic reporter gene is completely lost by third instar in zygotically HP1 mutant larvae, implying a defect in heterochromatin-mediated transcriptional regulation in these larvae. However, expression of the essential heterochromatic genes rolled and light is reduced in Su(var)2-5 mutant larvae, suggesting that reduced expression of essential heterochromatic genes could underlie the recessive lethality of Su(var)2-5 mutations. These results also show that HP1, initially recognized as a transcriptional silencer, is required for the normal transcriptional activation of heterochromatic genes.


Subject(s)
Chromosomal Proteins, Non-Histone/physiology , Drosophila/genetics , Gene Expression Regulation/physiology , Heterochromatin/genetics , Animals , Chromobox Protein Homolog 5 , Drosophila/growth & development , Heterozygote , Homozygote , Larva/metabolism , Phenotype
10.
Development ; 125(12): 2223-34, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9584122

ABSTRACT

The roles of differentiation, mitotic activity and intrinsic promoter strength in the maintenance of heterochromatic silencing were investigated during development using an inducible lacZ gene as an in vivo probe. Heterochromatic silencing is initiated at the onset of gastrulation, approximately 1 hour after heterochromatin is first visible cytologically. A high degree of silencing is maintained in the mitotically active imaginal cells from mid-embryogenesis until early third instar larval stage, and extensive relaxation of silencing is tightly associated with the onset of differentiation. Relaxation of silencing can be triggered in vitro by ecdysone. In contrast, timing and extent of silencing at both the initiation and relaxation stages are insensitive to changes in cell cycle activity, and intrinsic promoter strength also does not influence the extent of silencing by heterochromatin. These data suggest that the silencing activity of heterochromatin is developmentally programmed.


Subject(s)
Drosophila/genetics , Embryo, Nonmammalian/physiology , Gene Expression Regulation, Developmental , Genes, Insect , Heterochromatin/physiology , Animals , Cell Cycle , Cell Differentiation , Drosophila/embryology , Drosophila/growth & development , Ecdysone/pharmacology , Gastrula/physiology , Gene Expression Regulation, Developmental/drug effects , Lac Operon , Larva/physiology , Models, Genetic , Promoter Regions, Genetic , Pupa/physiology , beta-Galactosidase/metabolism
11.
Cell Mol Life Sci ; 54(1): 50-9, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9487386

ABSTRACT

Transcriptional silencing by heterochromatin represents a model for developmental gene silencing. Current models of heterochromatin envision DNA-protein complexes that prevent access by euchromatic transcription factors. Here, we summarize the evidence that heterochromatin acts at the chromatin level to silence genes and the status of current models of heterochromatin silencing, and we highlight some recent progress in understanding the composition and regulation of heterochromatin in Drosophila.


Subject(s)
Drosophila/genetics , Gene Expression Regulation, Developmental/genetics , Heterochromatin/genetics , Animals , Heterochromatin/chemistry , Models, Biological
12.
J Dent Res ; 76(1): 575-9, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9042080

ABSTRACT

Short-chain carboxylic acids (e.g., lactic acid, propionic acid, butyric acid) are metabolic by-products of bacterial metabolism which can accumulate in the gingival crevice. It is of no small consequence, therefore, that 1- to 5-mM concentrations of these acids exhibit significant biological activity, including the ability to alter cell proliferation and gene expression in cells of importance to the periodontium. This communication reports on the in vivo concentrations of propionic and butyric acid in the gingival crevices of periodontal subjects with severe and mild disease. The results indicated that severely diseased subjects exhibited a > 10-fold increase in the mM concentration of these acids when compared with mildly diseased subjects (mean propionic acid-severe = 9.5 +/- 1.8 mM, and mild = 0.8 +/- 0.3 mM; mean butyric acid-severe = 2.6 +/- 0.4 mM, and mild = 0.2 +/- 0.04 mM). These differences (mean +/- SE) were significant (p < 0.0001). The propionic and butyric acid concentrations were below detection limits in healthy sites of mildly diseased subjects. The propionic and butyric acid concentrations also associated significantly with clinical measures of disease severity (e.g., pocket depth, attachment level) and inflammation (e.g., subgingival temperature, % of sites bleeding when probed), and with the total microbial load (all p < 0.05). Taken together, these data suggest that short-chain carboxylic acids play a mediating role in periodontal disease pathogenesis.


Subject(s)
Butyrates/analysis , Gingival Crevicular Fluid/chemistry , Periodontitis/metabolism , Periodontitis/microbiology , Propionates/analysis , Aggregatibacter actinomycetemcomitans/isolation & purification , Aggregatibacter actinomycetemcomitans/metabolism , Butyric Acid , Campylobacter/isolation & purification , Campylobacter/metabolism , Colony Count, Microbial , Eikenella corrodens/isolation & purification , Eikenella corrodens/metabolism , Fusobacterium nucleatum/isolation & purification , Fusobacterium nucleatum/metabolism , Humans , Periodontal Index , Porphyromonas gingivalis/isolation & purification , Porphyromonas gingivalis/metabolism , Prevotella intermedia/isolation & purification , Prevotella intermedia/metabolism , Statistics, Nonparametric , Treponema/isolation & purification , Treponema/metabolism
13.
Biochem Biophys Res Commun ; 229(1): 287-94, 1996 Dec 04.
Article in English | MEDLINE | ID: mdl-8954120

ABSTRACT

The enzymatic mechanism of a small ribosome-inactivating protein, gamma-momorcharin, purified from the seeds of Momordica charantia, has been characterized. By SDS-polyacrylamide and electrospray ionization mass spectrometry, its molecular weight was measured to be 11,500 daltons which is much lower than other RIPs known to date. It can inhibit the protein synthesis in the rabbit reticulocyte cell-free system with ID50 of 55 nM. When rat liver ribosome was incubated with gamma-momorcharin, a diagnostic RNA fragment appeared on the gel after rRNAs were treated with acid aniline. Sequencing of the RNA fragment indicates that the action site of gamma-momorcharin in 28S ribosomal RNA of rat liver is at a specific adenosine (position 4324), which is in a highly conserved loop of 28S rRNA.


Subject(s)
N-Glycosyl Hydrolases/metabolism , Plant Proteins/metabolism , Plants, Medicinal/enzymology , Protein Synthesis Inhibitors/metabolism , RNA, Ribosomal, 28S/metabolism , Ribosomal Proteins , Dose-Response Relationship, Drug , N-Glycosyl Hydrolases/pharmacology , Plant Proteins/pharmacology , Protein Biosynthesis/drug effects , Protein Synthesis Inhibitors/pharmacology , Ribosome Inactivating Proteins , Ribosomes/drug effects , Seeds/chemistry , Substrate Specificity
14.
J Clin Periodontol ; 23(8): 743-9, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8877660

ABSTRACT

Short-chain carboxylic acids (SCCA; C < or = 5; e.g., lactic acid, propionic acid, butyric acid) are metabolic by-products of bacterial metabolism which accumulate in the gingival crevice, and exhibit significant biological activity, including the ability to alter gene expression. It has been hypothesized that among the activities of SCCAs are their ability to contribute to gingival inflammation. This concept complements the notion that specific periodontal pathogens are the causative agents of gingival inflammation. To begin testing these 2 hypotheses, we examined the relationship between SCCA concentrations, specific putative periodontal pathogens, and gingival inflammation in medically healthy periodontally diseased subjects. We reasoned that if SCCAs and/or specific periodontal pathogens were causative gingival inflammatory agents, gingival inflammation should increase with increasing concentration of the inflammatory mediator. We also recognized that other clinical variables needed to be controlled for, and an objective quantitative assessment of gingival inflammation used. To accomplish these tasks, sites within subjects were stratified by location and pocket depth, and the following quantified: bacterial presence; SCCA concentration; and gingival inflammation. The results indicated that gingival inflammation directly and significantly correlated with SCCA concentrations in the maxillary and mandibular molars, incisors and canines (all r > or = 0.47; all p < or = 0.015; too few bicuspids were available for complete analysis). The relationship between gingival inflammation and SCCA concentration was best described by a natural log relationship. Gingival inflammation did not, however, correlate positively with either the total number of specific putative periodontal pathogens, or the sum of subsets of these pathogens (-0.31 < or = r < or = 0.39; 0.08 < or = p < or = 0.75) for any of the locations. Finally, the SCCA concentration did not correlate with the level of individual or groups of pathogens. These data, together with historical work and other preliminary data, support the hypothesis that SCCA, rather than specific putative periodontal pathogens, may be a causative agent in gingival inflammation. This work may, in part, begin to explain the apparent lack of a direct relationship between current gingival inflammation and the prediction of bacterially mediated periodontal attachment loss.


Subject(s)
Fatty Acids, Volatile/metabolism , Gingival Crevicular Fluid/chemistry , Gingivitis/metabolism , Gingivitis/microbiology , Aggregatibacter actinomycetemcomitans/isolation & purification , Aggregatibacter actinomycetemcomitans/metabolism , Bacteria, Anaerobic/metabolism , Bacteria, Anaerobic/pathogenicity , Campylobacter/isolation & purification , Campylobacter/metabolism , Eikenella corrodens/isolation & purification , Eikenella corrodens/metabolism , Fusobacterium nucleatum/isolation & purification , Fusobacterium nucleatum/metabolism , Gingival Crevicular Fluid/microbiology , Humans , Porphyromonas gingivalis/isolation & purification , Porphyromonas gingivalis/metabolism , Prevotella intermedia/isolation & purification , Prevotella intermedia/metabolism , Treponema/isolation & purification , Treponema/metabolism
15.
EMBO J ; 15(6): 1323-32, 1996 Mar 15.
Article in English | MEDLINE | ID: mdl-8635465

ABSTRACT

Heterochromatic position-effect variegation (PEV) describes the mosaic phenotype of a euchromatic gene placed next to heterochromatin. Heterochromatin-mediated silencing has been studied extensively in Drosophila, but the lack of a ubiquitous reporter gene detectable at any stage has prevented a direct developmental characterization of this phenomenon. Current models attribute variegation to the establishment of a heritable silent state in a subset of the cells and invoke differences in the timing of silencing to explain differences in the patch size of various mosaic patterns. In order to follow the course of heterochromatic silencing directly, we have generated Drosophila lines variegating for a lacZ reporter that can be induced in virtually all cells at any developmental stage. Our data indicate that silencing begins in embryogenesis and persists in both somatic and germline lineages. A heterogeneity in the extent of silencing is also revealed; silencing is suppressed in differentiated tissues but remains widespread in larval imaginal discs containing precursor cells for adult structures. Using eye development as an example, we propose that the mosaic phenotype is determined during differentiation by a variegated relaxation in heterochromatic silencing. Though unpredicted by prevailing models, this mechanism is evident in other analogous systems.


Subject(s)
Drosophila/genetics , Gene Expression Regulation, Developmental , Genes, Insect , Heterochromatin/physiology , Animals , Cell Differentiation , Chromosomes/ultrastructure , Genes, Reporter , Germ Cells , Lac Operon , Time Factors
16.
Biomed Environ Sci ; 8(4): 342-9, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8719176

ABSTRACT

A study on smoking-attributable health economic costs in China was conducted from 1988-1992, in which three major categories of chronic diseases, diseases of cancer, diseases of circulatory system, and diseases of respiratory system were included. A prevalence-based method which estimated the cumulative effect of cigarette smoking during the past 20-30 years was used. The results show that in 1989, the total smoking-attributable economic costs to health sectors in China were about 27.1 billion of Chinese Yuan, including about 7 billion Yuan in direct medical costs and 20 billion Yuan in indirect costs, which include indirect morbidity costs and indirect mortality costs. The relatively low direct costs reflected the low medical costs at hospitals in China at that time. And the high proportion of indirect costs relative to the total costs shows the high potential years of life lost due to cigarette smoking. The results also show the heavier health burden in urban areas than in rural areas, reflecting the worse situation in urban China at nowadays. But if considering that almost 80% of the Chinese are rural farmers with the higher smoking prevalence and relatively shorter history of manufactured cigarette smoking than their urban counterparts, the very frightful situation due to cigarette smoking would be for China in the next century.


Subject(s)
Smoking/economics , Cardiovascular Diseases/economics , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/etiology , Cerebrovascular Disorders/economics , Cerebrovascular Disorders/epidemiology , Cerebrovascular Disorders/etiology , China/epidemiology , Costs and Cost Analysis , Evaluation Studies as Topic , Female , Health Surveys , Humans , Male , Neoplasms/economics , Neoplasms/epidemiology , Neoplasms/etiology , Peptic Ulcer/economics , Peptic Ulcer/epidemiology , Peptic Ulcer/etiology , Prevalence , Respiratory Tract Diseases/economics , Respiratory Tract Diseases/epidemiology , Respiratory Tract Diseases/etiology , Smoking/adverse effects
17.
J Clin Periodontol ; 22(10): 804-9, 1995 Oct.
Article in English | MEDLINE | ID: mdl-8682928

ABSTRACT

Elevated temperature is one of 4 cardinal inflammatory signs. Previous work indicates that subgingival temperature assessments are accurate and re- liable, and provide objective, quantitative information over a broad 10 degrees C range, in small 0.1 degrees C increments with a direct, immediate report on the inflammatory status at the pocket base. However, complicating the use and interpretation of subgingival temperature assessments are its 3 forms: actual subgingival temperature, sublingual temperature minus subgingival temperature (temperature differential), and a temperature indicator light. We reasoned that if one could determine which of the temperature assessments reflected the periodontal condition, and which were independent variables, they would provide new and unique information about the inflammatory status of the periodontium. We also reasoned that by providing objective, quantitative data over a broad range, subgingival temperature should reduce the sample size required to obtain significance in clinical trials. Therefore, the purpose of this study was 2-fold: (1) to determine whether the 3 subgingival temperature assessments could differentiate between clinically defined periodontal health and disease; (2) to determine whether the 3 assessments were dependent or independent clinical variables. The data indicated that all 3 subgingival temperature assessment methods differentiated between clinically-defined periodontal health and disease (all p<0.02). All 3 assessments also correlated significantly (all p<0.03), but modestly (all r>0.49), with bleeding on probing. Based on scatter-plot matrices and common factor analysis, the data indicated that only actual subgingival temperature and temperature differential were independent variables. Taken together, this data indicates that subgingival temperature and temperature differential provide unique information about the periodontal inflammatory state. Power calculations indicated that the temperature differential may significantly reduce the subject number required to achieve significance in clinical trials examining gingival inflammation. Because of the body's rapid temperature response, these assessments may also significantly reduce the time required for gingival inflammation trials.


Subject(s)
Body Temperature , Gingiva/physiology , Gingivitis/physiopathology , Analysis of Variance , Clinical Trials as Topic , Factor Analysis, Statistical , Gingival Hemorrhage/pathology , Gingival Hemorrhage/physiopathology , Gingival Pocket/pathology , Gingival Pocket/physiopathology , Gingivitis/diagnosis , Gingivitis/pathology , Humans , Periodontal Attachment Loss/pathology , Periodontal Attachment Loss/physiopathology , Periodontal Diseases/diagnosis , Periodontal Diseases/physiopathology , Periodontal Pocket/pathology , Periodontal Pocket/physiopathology , Periodontitis/pathology , Periodontitis/physiopathology , Periodontium/physiology , Reproducibility of Results , Research Design , Sample Size , Tongue/physiology
18.
J Gastroenterol Hepatol ; 9(2): 169-71, 1994.
Article in English | MEDLINE | ID: mdl-7516195

ABSTRACT

Hepatitis C virus (HCV) has been subdivided into at least four genotypes, and the prevalence of each genotype has been reported to differ widely in different countries. Of 304 patients with chronic liver diseases (68 with chronic hepatitis, 50 with liver cirrhosis and 186 with hepatocellular carcinoma) from Guangxi Province in southern China, only 9 (3.0%) had antibodies to HCV as determined by a second-generation enzyme immunoassay with a cut-off index of 2.0 or more. The HCV genotypes of these nine cases were examined using polymerase chain reaction with type-specific primers deduced from putative core gene. Seven of the nine cases had type II infection and the other two cases showed double infection with types II and IV. These findings indicate that the predominant HCV genotype in the Guangxi area is type II, as is the case in Japan, although the prevalence of HCV infection in patients with chronic liver diseases is much lower.


Subject(s)
Hepacivirus/genetics , Hepatitis C/epidemiology , Adolescent , Adult , Aged , China/epidemiology , Female , Genotype , Hepacivirus/immunology , Hepatitis Antibodies/analysis , Hepatitis B Surface Antigens/analysis , Hepatitis C/immunology , Hepatitis C/microbiology , Hepatitis C Antibodies , Humans , Male , Middle Aged , Polymerase Chain Reaction , Prevalence
19.
Cancer ; 73(1): 58-62, 1994 Jan 01.
Article in English | MEDLINE | ID: mdl-7506119

ABSTRACT

BACKGROUND: The incidence of hepatocellular carcinoma (HCC) in southern China, including Guangxi Province, is among the highest in the world. Investigations of the etiology of HCC in this area have focused on hepatitis B virus (HBV) and aflatoxin. However, hepatitis C virus (HCV) has been shown to be a possible pathogenic agent for HCC in a number of countries. METHODS: Antibodies to HCV (anti-HCV), determined by second-generation enzyme immunoassay, and hepatitis B surface antigen (HBsAg) were assayed in the sera of 186 patients with HCC and 48 healthy control subjects from Guangxi Province in southern China. RESULTS: HBsAg was detected in 131 (70.4%) of 186 patients with HCC, whereas only 10 (5.4%) patients were found to be positive for anti-HCV. The prevalence of anti-HCV in patients with HBsAg-positive HCC was 6.9% (9 of 131) and that in patients with HBsAg-negative HCC was 1.8% (1 of 55); there was no significant difference between these two groups. Anti-HCV was not detected in any of the healthy control subjects, in whom the prevalence of HBsAg was 10.4% (5 of 48). CONCLUSIONS: These findings indicate that HCV does not seem to play an important role in the development of HCC in Guangxi Province; however, HBV infection appears to be a major pathogenic factor for HCC in this area.


Subject(s)
Carcinoma, Hepatocellular/microbiology , Hepacivirus/immunology , Hepatitis Antibodies/blood , Liver Neoplasms/microbiology , Adult , Aged , Carcinoma, Hepatocellular/blood , China , Female , Hepatitis B Surface Antigens/blood , Humans , Liver Neoplasms/blood , Male , Middle Aged , Prevalence , alpha-Fetoproteins/analysis
20.
Zhonghua Fu Chan Ke Za Zhi ; 25(6): 325-7, 382, 1990 Nov.
Article in Chinese | MEDLINE | ID: mdl-2282856

ABSTRACT

Selenium concentration of maternal blood, urine, placenta and cord blood were determined in 30 cases of normal late pregnancy and 40 cases of PIH. The results showed: selenium concentration of maternal blood, urine and placenta were obviously lower in PIH than that in normal pregnant women. The more severe was the PIH the lower was the selenium level. There was no significant difference in cord blood between 2 groups. The selenium concentration of neonatal infant blood was higher than that of maternal blood. A positive correlation of selenium concentrations was observed between maternal blood and placenta in patients with severe PIH.


Subject(s)
Pre-Eclampsia/metabolism , Selenium/metabolism , Adult , Female , Fetal Blood/chemistry , Humans , Placenta/chemistry , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...